Citations available for content in Chicago, APA and MLA format.
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Notice. "Oncologic Drugs Advisory Committee; Amendment of Notice" Federal Register 74, no. 173 (September 9, 2009): 46435. https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21556.
Office of the Federal Register, National Archives and Records Administration. (). 74 FR 46435 - Oncologic Drugs Advisory Committee; Amendment of Notice. [Government]. Office of the Federal Register, National Archives and Records Administration. https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21556
Office of the Federal Register, National Archives and Records Administration. 74 FR 46435 - Oncologic Drugs Advisory Committee; Amendment of Notice. Office of the Federal Register, National Archives and Records Administration, , https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21556
Office of the Federal Register, National Archives and Records Administration, Oncologic Drugs Advisory Committee; Amendment of Notice, govinfo, (September 9, 2009), https://www.govinfo.gov/app/details/FR-2009-09-09/E9-21556.
Close xFederal Register Volume 74, Issue 173 (September 9, 2009)
Regulatory Information
Federal Register
AE 2.7:
GS 4.107:
AE 2.106:
Office of the Federal Register, National Archives and Records Administration
Notices
Notice.
Nicole Vesely, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-6793, FAX: 301-827-6776, e-mail: nicole.vesely@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512542. Please call the Information Line for up-to-date information on this meeting.
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
46435-46435
74 FR 46435
Docket No. FDA-2009-N-0664
E9-21556